EDMONTON, Alberta--BioTools and Varian have agreed to develop a new magnetic resonance diagnostic tool over the course of an expected three-year project. The effort will involve the clinical application of nuclear magnetic resonance spectroscopy and advanced computational tools such as pattern recognition to the diagnosis and monitoring of disease and health. It also has potential applications in drug and toxicity testing.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.